What Comes Next for Hca Healthcare, (NYSE:HCA)?
Follow Hca Healthcare, as investors assess clinical demand and healthcare delivery, the current catalyst, execution risks and the company evidence that may sha…


Glideslope AI-powered market news
2 stories in the last 7 days, reading neutral overall. Quiet in the last 24 hours.

| Day | Mood | Stories |
|---|---|---|
| Fri, Oct 9 | — | 0 |
| Thu, Oct 8 | — | 0 |
| Wed, Oct 7 | — | 0 |
| Tue, Oct 6 | 0.0 | 1 |
| Mon, Oct 5 | — | 0 |
| Sun, Oct 4 | — | 0 |
| Sat, Oct 3 | — | 1 |
| Fri, Oct 2 | — | 0 |
Follow Hca Healthcare, as investors assess clinical demand and healthcare delivery, the current catalyst, execution risks and the company evidence that may sha…

Emily Pearson was diagnosed with a rare condition that left her vulnerable to sun as a teenager. A new medication offers hope.

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly's Zepbound. Its stock is soaring.
The chronic myeloid leukemia clinical trial analysis report delivers important insights into ongoing research of 25+ pipeline chronic myeloid leukemia drugs, c…

Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.

AUSTIN, Texas, September 01, 2026--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the publication of new…

Heather Berlin, a neuroscientist, clinical psychologist and clinical professor at the Icahn School of Medicine at Mount Sinai, joins "The Daily Report" to expl…

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.

The lawsuits target a range of businesses that allegedly marketed retatrutide products to consumers despite the drug remaining under clinical development.

Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide v…
Legal challenge to King's College London research study claimed it could harm participants but was rejectedA clinical trial of drugs that can delay puberty can…

Hernando Salcedo was diagnosed with Stage III pancreatic cancer after mild symptoms. Chemotherapy made him feel worse than before his diagnosis.

Illumina, Inc. recently expanded its Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., an independent director and Eli Lilly's Ch…
Novo Nordisk's 7.2 mg dose of Wegovy will compete against Lilly's GLP-1 injection.
Recruitment of children for study delayed after MHRA warns that participants should be no younger than 14 A clinical trial into puberty blockers for children h…

Bristol Myers' stock rallied Wednesday as investors maintained high hopes for Cobenfy as an Alzheimer's treatment, even though the outcome of a late-stage tria…
Washington University Medicine in St. Louis is conducting important research into treating early-onset Alzheimer's before symptoms arise.

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

The mid-stage trial results announced by the pharmaceutical giant showed that patients taking orforglipron lost an average of 16 pounds.

(RTTNews) - Benitec Biopharma Inc. (BNTC), a clinical-stage biotechnology company, Wednesday announced sustained improvements in swallowing function and reduce…
(RTTNews) - Clearmind Medicine Inc. (CMND), a clinical-stage biotech company, has launched its Phase I/IIa clinical trial to evaluate the safety, tolerability,…
(RTTNews) - Zentalis Pharmaceuticals Inc. (ZNTL) announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients w…
(RTTNews) - Microsoft Corp. has introduced Microsoft Dragon Copilot, an advanced AI assistant designed to revolutionize clinical workflows. This innovative too…
Jasper Therapeutics presents briquilimab clinical data at AAAAI 2025, showing safety and efficacy for chronic mast cell diseases.
Doctors are tweaking their treatment of Pope Francis, the 88-year-old leader of the Catholic Church, as he battles a respiratory tract infection.
Uganda has begun a clinical trial of a vaccine against the Sudan strain of Ebola following an outbreak that has killed one nurse in the east African country.

Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE